Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare, endocrine disease characterized by autoimmune thyroid disease associated with at least one other autoimmune disease, such as type I diabetes mellitus, chronic atrophic gastritis, pernicious anemia, vitiligo, alopecia, or myasthenia gravis, but excluding Addison disease.
Biomarker and diagnostic research for autoimmune polyendocrinopathy type 3 has been reported in the published literature.
No clinical trials have been registered for autoimmune polyendocrinopathy type 3.
32 publications have been identified in PubMed for autoimmune polyendocrinopathy type 3. Research spans Case Report / Case Series (50%), Epidemiology / Natural History (22%), and Review / Meta-Analysis (13%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 16 | 50% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 3:30 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Disease patterns and progression
7 |
22% |
Research summaries | 4 | 13% |
Laboratory research | 3 | 9% |
Testing and diagnosis research | 1 | 3% |
Clinical study results | 1 | 3% |
Hwang J (2026). [PMID: 41778090](https://pubmed.ncbi.nlm.nih.gov/41778090/). *Am J Ophthalmol Case Rep*. [Case Report / Case Series]
Butler K (2026). [PMID: 41782401](https://pubmed.ncbi.nlm.nih.gov/41782401/). *Curr Opin Gastroenterol*. [Review / Meta-Analysis]
Yang J (2026). [PMID: 41653277](https://pubmed.ncbi.nlm.nih.gov/41653277/). *J Clin Immunol*. [Case Report / Case Series]
Ottu Para NK (2026). [PMID: 41924408](https://pubmed.ncbi.nlm.nih.gov/41924408/). *Cureus*. [Case Report / Case Series]
Ataş Ü (2026). [PMID: 40996884](https://pubmed.ncbi.nlm.nih.gov/40996884/). *Turk J Haematol*. [Case Report / Case Series]
Sandini E (2026). [PMID: 41394114](https://pubmed.ncbi.nlm.nih.gov/41394114/). *J Endocr Soc*. [Epidemiology / Natural History]
Qiu Y (2025). [PMID: 40597940](https://pubmed.ncbi.nlm.nih.gov/40597940/). *BMC Endocr Disord*. [Clinical Trial Publication]
Mabuchi S (2025). [PMID: 40502940](https://pubmed.ncbi.nlm.nih.gov/40502940/). *Eur J Case Rep Intern Med*. [Case Report / Case Series]
Katayama T (2025). [PMID: 39971298](https://pubmed.ncbi.nlm.nih.gov/39971298/). *Intern Med*. [Case Report / Case Series]
Chikhaoui A (2025). [PMID: 41190326](https://pubmed.ncbi.nlm.nih.gov/41190326/). *Front Genet*. [Case Report / Case Series]